[Ip-health] New Tufts study on R&D costs

Elizabeth Rajasingh elizabeth.rajasingh at gmail.com
Fri Nov 14 17:16:09 PST 2014


I'm betting on... $2.19 billion

----
Elizabeth Rajasingh
e*lizabeth.rajasingh at gmail.com* <elizabeth.rajasingh at gmail.com> |
 410-829-7866
University of Virginia, Class of 2014
Global Development and Public Health

On Fri, Nov 14, 2014 at 12:35 PM, Jamie Love <james.love at keionline.org>
wrote:

> Next week, a new version of the Tufts study on R&D costs will be released.
>
> KEI will give $50 to the person who comes the closed in predicting the new
> figure for the cost of R&D for the lead indication of a new chemical
> entity.
>
> An abstract of the earlier 2003 study,"The price of innovation: new
> estimates of drug development costs" is available here:
>
> http://www.ncbi.nlm.nih.gov/pubmed/12606142
>
>
> The 2003 study put the number at $802 million (not $800 million, but $802
> million), in 2000 dollars.
>
> As I said, $50 for the closest estimate, published on IP-Health, before the
> new number is announced (or leaked).
>
> Jamie
>
> --
> James Love.  Knowledge Ecology International
> http://www.keionline.org/donate.html
> KEI DC tel: +1.202.332.2670, US Mobile: +1.202.361.3040, Geneva Mobile:
> +41.76.413.6584, twitter.com/jamie_love
> _______________________________________________
> Ip-health mailing list
> Ip-health at lists.keionline.org
> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org
>



More information about the Ip-health mailing list